Dentsply Sirona Inc (XRAY)
19.39 -0.43 (-2.17%)
Dentsply Sirona Inc is a global leader in the dental industry, specializing in the manufacturing and distribution of a wide range of dental products and technologies. The company provides innovative solutions for dental professionals, including equipment, instruments, and materials used in various dental procedures, such as restorative, preventive, and orthodontic care. Dentsply Sirona focuses on improving patient outcomes through advancements in dental technology, offering products that enhance treatment efficiency and effectiveness. By catering to dental professionals worldwide, the company plays a pivotal role in enhancing oral health and clinical practice standards.
Previous Close | 19.82 |
---|---|
Open | 19.61 |
Bid | 19.03 |
Ask | 19.49 |
Day's Range | 19.01 - 19.83 |
52 Week Range | 17.21 - 37.60 |
Volume | 2,828,506 |
Market Cap | 3.85B |
PE Ratio (TTM) | -9.459 |
EPS (TTM) | -2.0 |
Dividend & Yield | 0.6400 (3.30%) |
1 Month Average Volume | 4,691,365 |
News & Press Releases
DENTSPLY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DENTSPLY SIRONA Inc. and Encourages Investors to Contact the Firm
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. (“Dentsply” or the “Company”) (NASDAQ:XRAY) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Dentsply securities between December 1, 2022 and November 6 2024, both dates inclusive (the “Class Period”). Investors have until January 27, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · December 3, 2024
SHAREHOLDER DEADLINE NOTICE: Scott+Scott Attorneys at Law LLP Notifies Investors that a Securities Class Action Has Been Filed Against Dentsply Sirona, Inc. (NASDAQ: XRAY)
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, notifies investors that the deadline to move for lead plaintiff in a securities class action lawsuit against Dentsply Sirona, Inc. (NASDAQ: XRAY) (“Dentsply” or the “Company”) and certain other defendants (collectively, “Defendants”) is January 27, 2025.
By Scott+Scott Attorneys at Law LLP · Via Business Wire · December 2, 2024
XRAY Investors Have Opportunity to Lead DENTSPLY SIRONA Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DENTSPLY SIRONA Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · December 2, 2024
XRAY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Dentsply Sirona Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY) and certain of its officers.
By Bronstein, Gewirtz & Grossman, LLC · Via Business Wire · December 2, 2024
Dentsply Sirona Inc. Investor Alert: Robbins LLP Reminds XRAY Stockholders of the Pending Class Action
SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased Dentsply Sirona Inc. (NASDAQ: XRAY) common stock between December 1, 2022 and November 6, 2024. Dentsply manufactures professional dental products, for example, CAD/CAM computer-aided design and manufacturing systems, imaging equipment, motorized dental handpieces, consumables (e.g., files, sealers, needles), implants, prosthetics, and orthodontics, such as clear aligners.
By Robbins LLP · Via GlobeNewswire · December 2, 2024
DENTSPLY SIRONA INC. (NASDAQ: XRAY) INVESTOR ALERT: Investors With Large Losses in DENTSPLY SIRONA Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of DENTSPLY SIRONA Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) between December 1, 2022 and November 6, 2024, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · December 2, 2024
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 10 Analystsbenzinga.com
Via Benzinga · July 18, 2024
Rosen Law Firm Urges Dentsply Sirona Inc. (NASDAQ: XRAY) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between December 1, 2022 and November 6, 2024. Dentsply describes itself as a company that “manufactures professional dental products.”
By The Rosen Law Firm, P.A. · Via Business Wire · November 27, 2024
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Dentsply To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · November 27, 2024
NASDAQ: XRAY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Investors with Significant Losses to Contact the Firm
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) (“DENTSPLY”).
By Kessler Topaz Meltzer & Check, LLP · Via Business Wire · November 15, 2024
Evaluating Dentsply Sirona: Insights From 8 Financial Analystsbenzinga.com
Via Benzinga · June 25, 2024
Crude Oil Rises 1%; US Jobless Claims Increase To 221,000benzinga.com
Via Benzinga · November 7, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · November 7, 2024
Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demandbenzinga.com
Dentsply Sirona Q3 earnings beat estimates, but a $495M goodwill impairment and lowered sales outlook cause stock to drop 22%.
Via Benzinga · November 7, 2024
Tesla To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Mondaybenzinga.com
Via Benzinga · October 28, 2024
Critical Insights From Dentsply Sirona Analyst Ratings: What You Need To Knowbenzinga.com
Via Benzinga · August 20, 2024
Dentsply Sirona Misses Q2 Targets - Plans Restructuring Plan Amid Weak Demandbenzinga.com
Via Benzinga · July 31, 2024
XRAY Stock Earnings: Dentsply Sirona Misses EPS, Misses Revenue for Q2 2024investorplace.com
XRAY stock results show that Dentsply Sirona missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · July 31, 2024
XRAY Investors Have the Opportunity to Join Investigation of DENTSPLY SIRONA Inc. with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY) for potential breaches of fiduciary duty on the part of its directors and management.
By The Schall Law Firm · Via Business Wire · June 26, 2024
$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buyingbenzinga.com
Via Benzinga · June 4, 2024
7 Long-Term Stocks to Buy Now: May 2024investorplace.com
While anything can happen in the markets from day to day, over the long-term, these seven long-term stocks to buy should prosper regardless.
Via InvestorPlace · May 22, 2024